Article Details
Retrieved on: 2025-01-22 18:27:02
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
On Wednesday, Cantor Fitzgerald analyst Ross Osborn increased the 12-month price target on Sanara MedTech shares to $46 from $44, while maintaining an ...
Article found on: www.investing.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here